Description

Tesamorelin Product Overview

Product Name: Tesamorelin Acetate (Lyophilized Powder)
Brand Name: Egrifta® (for pharmaceutical use) / Generic Tesamorelin (research & compounding)
CAS No.: 218949-48-5
Molecular Formula: C???H???N??O??S
Molecular Weight: 5135.9 g/mol
Purity: 98% (HPLC-verified)
Appearance: White to off-white lyophilized powder
Formulation: Sterile, freeze-dried powder for reconstitution

Product Specifications

1. Composition & Structure

• Active Ingredient: Tesamorelin acetate (a synthetic 44-amino acid peptide analog of Growth Hormone-Releasing Hormone, GHRH).

• Sequence: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH?

• Excipients (if included in pharmaceutical-grade): Mannitol (stabilizer), sodium phosphate (buffer), may contain HCl/NaOH for pH adjustment.

2. Storage & Stability

• Storage Conditions: 2–8°C (refrigerated), protect from light.

• Reconstituted Solution: Stable for up to 24 hours at 2–8°C after mixing with sterile water or bacteriostatic water.

• Shelf Life: Typically 24 months when stored properly in sealed vials.

3. Packaging Options (Wholesale)

• Vial Sizes: 1mg, 2mg, 5mg, 10mg per vial (research/compounding)

• Pharmaceutical Kits: Egrifta® 1 mg/vial (pre-filled syringes may be available)

• Bulk Quantities: 1g, 5g, 10g (custom orders available)

Primary Uses & Applications

1. Medical/Pharmaceutical Use

• FDA-Approved Indication: Reduction of excess visceral abdominal fat in HIV patients with lipodystrophy.

• Off-Label Uses:

  • Anti-aging & growth hormone deficiency (research-stage)

  • Metabolic disorders (investigational)

2. Research Applications

• Mechanism of Action: Binds to GHRH receptors, stimulating pituitary release of growth hormone (GH) and IGF-1.

• Studies Include:

  • Fat metabolism & body composition

  • Age-related GH decline

  • Muscle wasting disorders

Advantages for Wholesale Buyers

• High Purity: GMP-compliant synthesis with HPLC/MS verification.

• Custom Formulations: Available with or without excipients (e.g., mannitol-free for compounding).

• Global Compliance: Meets USP, EP, and ICH standards; COA provided.

• Scalable Supply: Bulk orders (grams to kilograms) with flexible packaging.

Ordering & Compliance

• MOQ: Varies (e.g., 10 vials for retail, 1g+ for bulk).

• Regulatory Notes:

  • Pharmaceutical-grade requires prescription (Egrifta®).

  • Research-grade must be labeled “Not for Human Consumption” (if unlicensed).

Target Customers:

• Compounding pharmacies

• Anti-aging clinics

• Research institutions

• Peptide distributors